1. Home
  2. SVCO vs CGEN Comparison

SVCO vs CGEN Comparison

Compare SVCO & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • CGEN
  • Stock Information
  • Founded
  • SVCO 1984
  • CGEN 1993
  • Country
  • SVCO United States
  • CGEN Israel
  • Employees
  • SVCO N/A
  • CGEN N/A
  • Industry
  • SVCO
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SVCO
  • CGEN Health Care
  • Exchange
  • SVCO NYSE
  • CGEN Nasdaq
  • Market Cap
  • SVCO 140.5M
  • CGEN 167.4M
  • IPO Year
  • SVCO 2024
  • CGEN 2000
  • Fundamental
  • Price
  • SVCO $4.74
  • CGEN $1.65
  • Analyst Decision
  • SVCO Strong Buy
  • CGEN
  • Analyst Count
  • SVCO 5
  • CGEN 0
  • Target Price
  • SVCO $17.00
  • CGEN N/A
  • AVG Volume (30 Days)
  • SVCO 89.2K
  • CGEN 265.0K
  • Earning Date
  • SVCO 08-06-2025
  • CGEN 08-05-2025
  • Dividend Yield
  • SVCO N/A
  • CGEN N/A
  • EPS Growth
  • SVCO N/A
  • CGEN N/A
  • EPS
  • SVCO N/A
  • CGEN N/A
  • Revenue
  • SVCO $57,883,000.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • SVCO $14.25
  • CGEN N/A
  • Revenue Next Year
  • SVCO $15.85
  • CGEN $173.80
  • P/E Ratio
  • SVCO N/A
  • CGEN N/A
  • Revenue Growth
  • SVCO 3.65
  • CGEN N/A
  • 52 Week Low
  • SVCO $3.55
  • CGEN $1.13
  • 52 Week High
  • SVCO $20.69
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • CGEN 51.95
  • Support Level
  • SVCO N/A
  • CGEN $1.58
  • Resistance Level
  • SVCO N/A
  • CGEN $1.81
  • Average True Range (ATR)
  • SVCO 0.00
  • CGEN 0.08
  • MACD
  • SVCO 0.00
  • CGEN -0.01
  • Stochastic Oscillator
  • SVCO 0.00
  • CGEN 20.00

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design (TCAD) software, electronic data automation (EDA) software and semiconductor intellectual property (SIP). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the technology behind the chip and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: